CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · IEX Real-Time Price · USD
70.16
-0.81 (-1.14%)
At close: Mar 27, 2024, 4:00 PM
70.55
+0.39 (0.56%)
Pre-market: Mar 28, 2024, 5:25 AM EDT

CRISPR Therapeutics AG Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Net Income
-153.61-650.18377.66-348.8766.86-164.98-68.36-23.18-25.5-7.01
Depreciation & Amortization
19.8424.1717.959.184.733.523.020.930.130.04
Share-Based Compensation
81.0397.95102.3966.0244.0634.9918.8710.843.680.7
Other Operating Activities
-207.6332.3240.9735.3-58.9630.24-23.63-41.4581.120.74
Operating Cash Flow
-260.38-495.74538.97-238.3756.68-96.24-70.09-52.8659.43-4.79
Capital Expenditures
-9.47-37.19-81.71-18.36-6.68-2.77-7.81-3.02-1.150
Acquisitions
00008.0100000
Change in Investments
386.62-221.47-953.73-522.8100-0.5-0.100
Other Investing Activities
-2.5------35--
Investing Cash Flow
374.65-258.66-1,035.43-541.171.33-2.77-8.3131.88-1.150
Share Issuance / Repurchase
62.6638.59250.951,016430.98315.932.6189.10.240.02
Debt Issued / Paid
000000035.0138.240
Other Financing Activities
-------59.1258.255.1
Financing Cash Flow
62.6638.59250.951,016430.98315.932.61183.2296.735.12
Exchange Rate Effect
0.07-0.08-0.010.040.02-0.020.04-0.240.010.25
Net Cash Flow
177.01-715.88-245.52236.66489216.9-75.76162.01155.020.58
Free Cash Flow
-269.85-532.93457.27-256.7249.99-99.01-77.91-55.8858.27-4.79
Free Cash Flow Margin
-72.69%-44484.89%49.98%-35705.70%17.26%-3169.40%-190.03%-1082.03%23592.71%-
Free Cash Flow Per Share
-3.41-6.866.02-3.890.92-2.06-1.95-4.5611.57-1.35
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).